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Abstract
The adenovirus E4 open reading frame 4 (E4orf4) protein contributes to regulation of the progression of virus infection.
When expressed individually, E4orf4 was shown to induce non-classical transformed cell-specific apoptosis in mammalian
cells. At least some of the mechanisms underlying E4orf4-induced toxicity are conserved from yeast to mammals, including
the requirement for an interaction of E4orf4 with protein phosphatase 2A (PP2A). A genetic screen in yeast revealed that the
Golgi apyrase Ynd1 associates with E4orf4 and contributes to E4orf4-induced toxicity, independently of Ynd1 apyrase
activity. Ynd1 and PP2A were shown to contribute additively to E4orf4-induced toxicity in yeast, and to interact genetically
and physically. A mammalian orthologue of Ynd1 was shown to bind E4orf4 in mammalian cells, confirming the
evolutionary conservation of this interaction. Here, we use mutation analysis to identify the cytosolic tail of Ynd1 as the
protein domain required for mediation of the E4orf4 toxic signal and for the interaction with E4orf4. We also show that
E4orf4 associates with cellular membranes in yeast and is localized at their cytoplasmic face. However, E4orf4 is membrane-
associated even in the absence of Ynd1, suggesting that additional membrane proteins may mediate E4orf4 localization.
Based on our results and on a previous report describing a collection of Ynd1 protein partners, we propose that the Ynd1
cytoplasmic tail acts as a scaffold, interacting with a multi-protein complex, whose targeting by E4orf4 leads to cell death.
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Introduction
The adenovirus E4orf4 protein is a multifunctional viral
regulator. Within the context of the virus, E4orf4 contributes to
temporal regulation of the progression of viral infection by down-
regulating early viral gene expression [1–4], inducing hypopho-
sphorylation of various viral and cellular proteins [4,5], facilitating
alternative splicing of adenovirus mRNAs [5], and regulating
protein translation through an interaction with the mTOR
pathway [6]. When E4orf4 is expressed individually in trans-
formed cells, it induces p53-independent cell death [7–9].
Oncogenic transformation of primary cells in tissue culture
sensitizes them to cell killing by E4orf4 [10], indicating that
E4orf4 research may have implications for cancer therapy.
Induction of cell death by E4orf4 has been reported to be
partially caspase-dependent in 293T cells, but it is caspase-
independent in other cell lines, suggesting that E4orf4 can induce a
non-classical apoptotic pathway, but can also maintain a crosstalk
between the non-classical and the caspase-dependent pathways
[8,11]. We have previously shown that E4orf4 interacts with the
heterotrimeric protein phosphatase 2A (PP2A) through a direct
association with its regulatory Ba/B55 or B9/B56 subunits [2,12].
The PP2A-E4orf4 interaction mediated by the Ba/B55, but not
the B9/B56 subunit is required for induction of cell death
[10,12,13]. E4orf4 also associates with members of the Src kinase
family leading to its Tyr-phosphorylation and to deregulation of
Src signaling, resulting in enhanced caspase-independent apoptosis
[14,15]. Analysis of E4orf4 mutants has further indicated that the
interactions of E4orf4 with PP2A and Src have a cell-line
dependent additive effect on E4orf4-induced cell death [16].
E4orf4 was reported to act both in the nucleus and in the
cytoplasm and membranes of mammalian cells [17–19]. A key
unresolved question is the identity of targets of the PP2A-B55-
E4orf4 complex involved in induction of non-classical apoptosis,
and the identity of further downstream elements participating in
this apoptotic pathway. To further dissect the E4orf4-regulated
process, the yeast S. cerevisiae was used as a model system. Although
yeast cells do not contain all the components of classical apoptotic
pathways, they have been previously used as tools for studying
human apoptosis-regulating proteins which yielded novel insights
into cell death mechanisms [20]. Furthermore, yeast and
mammalian PP2A subunits are very similar and thus the E4orf4-
PP2A interaction could potentially be conserved in yeast. Indeed,
E4orf4 was found to induce PP2A-dependent irreversible growth
arrest in yeast [21,22], indicating that the PP2A-dependent
E4orf4-induced cell death pathway is highly conserved in
evolution. This high degree of conservation was further confirmed
by experiments showing that E4orf4 mutants selected in yeast for
loss of their ability to induce toxicity, were also deficient in their
ability to induce cell death in mammalian cells [23].
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which uncovered a novel component of the E4orf4 cell death-
inducing network, called Ynd1. Ynd1 is a Golgi apyrase whose
enzymatic activity is required for regulation of nucleotide-sugar
import into the Golgi lumen [24,25]. This protein is inserted in the
Golgi membrane, its 500 N-terminal amino acids, including its
catalytic domain, are located in the Golgi lumen, whereas its 113
C-terminal residues are found at the cytoplasmic face of the Golgi
membrane. The transmembrane domain includes amino acids 501
to 517 [24,26]. We showed previously that Ynd1 interacted both
physically and functionally with Cdc55, the yeast orthologue of the
PP2A-B55 regulatory subunit. However, Ynd1 may not be a
downstream effector of the E4orf4-Cdc55 complex in yeast, since
Cdc55 and Ynd1 deletions confer additive resistance to E4orf4.
Moreover, although Ynd1 deletion confers partial resistance to
E4orf4 toxicity, overexpression of Cdc55 sensitizes ynd1D cells to
E4orf4 toxicity more efficiently than WT cells. E4orf4 was shown
to physically interact with Ynd1 in yeast and with the mammalian
Ynd1 orthologue, Golgi UDPase, in mammalian cells [27],
confirming the evolutionary conservation of this part of the
E4orf4 effector network. Surprisingly however, the Ynd1 apyrase
activity was shown to be dispensable for mediating E4orf4-induced
toxicity [27].
In the present report we investigate which Ynd1 protein
domains are required for mediating the E4orf4 signal. We show
that the cytosolic tail of Ynd1 is sufficient for efficiently mediating
E4orf4-induced toxicity and that it associates with the E4orf4
protein. However, E4orf4 membrane-association does not occur
exclusively due to the interaction with Ynd1 since E4orf4 is found
in membrane fractions both in the presence and in the absence of
this protein. The results presented here will allow us to focus future
research more clearly into the mechanisms underlying the
contribution of Ynd1 to E4orf4-induced cell death, by searching
for proteins associating with the Ynd1 cytoplasmic tail and
examining their functional interactions with E4orf4.
Materials and Methods
Yeast strains, media, and plasmids
All experiments were carried out in the ynd1D yeast strain
previously described [27]. Yeast cells were grown either in YPD
(1% yeast extract, 2% Bacto-peptone, 0.015% L-tryptophan, 2%
glucose) or in a synthetic medium containing the appropriate
amino acids [28]. For induction with galactose, cells were grown in
synthetic medium with 2% raffinose overnight. They were then
diluted to OD600 nm=0.3 and allowed to grow for two more hours
before the addition of galactose to 2%. Alternatively, cells were
grown in 2% glucose to mid-log phase, washed once in water, and
resuspended in 2% galactose.
Plasmids utilized in this work included: B3384 (also known as
p424-GAL1), containing a 2 m origin of replication, a TRP marker
and the GAL1 promoter driving the cloned cDNA [29], pGZ418
[24], B3394 (also known as p414-GALL), B3394-E4orf4, pDAD2
and pDAD2-E4orf4 [21]. To generate plasmid B3384-Ynd1, WT
Ynd1 containing a 59-Myc tag and a 39-HA tag was transferred by
BamHI digestion from pGZ148 [24] to plasmid B3384. Ynd1
deletion mutants were constructed as follows: The required region
of the cDNA was PCR-amplified from B3384-Ynd1 with primers
containing BamHI (59 primer) or EcoRI (39 primer) restriction
sites. The 59 primers for N-terminal deletions also encoded a Myc
tag, and the 39 primers for C-terminal deletions encoded an HA
tag. PCR-amplified fragments were cloned into plasmid B3384
and verified by sequencing. The primers used for the amplification
of the deletion mutants were: 59 primers: for N-terminal deletions:
371-Ynd1: 59- CGCGGATCCGTAACCATGGAGCAAAAG-
CTGATATCTGAAGAGGACTTGAATTGGACGCAAATAT-
TA -39; 468-Ynd1: 59- CGCGGATCCGTAACCATGGAG-
CAAAAGCTGATATCTGA
AGAGGACTTGAGTGAAAGAAGAACTAAG -39; Ynd1-
518: 59- CGCGGATCCGTAACCATGGAGCAAAAGCTGA-
TATCTGA
AGAGGACTTGCATAGGTCACACATAATC -39;3 9 prim-
ers: for N-terminal deletions: 371-Ynd1, 468-Ynd1, Ynd1-518: 59-
GGAATTCCTCAGGCGTAGTCCGGGACGTCATATGG -
39; for C-terminal deletions: 371-Ynd1-531, 468-Ynd1-531: 59-
GGAATTCCTCAGGCGTAGTCCGGGACGTCATATGGG-
TA
GTACAGACCGGAAAAACG -39.
Random Mutagenesis of Ynd1
Random mutagenesis of Ynd1 was performed using the
GeneMorph II EZClone Domain Mutagenesis Kit by Stratagene,
according to the manufacturer’s instructions.
A yeast Serial Dilution Assay
A starter of yeast cells was grown overnight at 30uC in the
appropriate liquid medium containing glucose as a carbon source.
Cells were diluted to OD600 nm=0.1 and were then serially diluted
five more times at a 1:5 ratio. 3 ml of each dilution were plated on
the appropriate selection plates containing either glucose or
galactose as a carbon source. The plates were incubated at 30uC
for 3–5 days.
A quantitative comparison of the mediation of E4orf4-
induced toxicity by the various Ynd1 mutants
ynd1D cells transformed with wild-type (WT) Ynd1, an empty
vector or each of the mutants, as well as E4orf4 or an empty
vector, were grown overnight in liquid medium containing glucose
as a carbon source. The yeast suspension was then diluted to
OD600 nm=0.05 and duplicate aliquots of each sample were
plated on the appropriate selection plates containing either
galactose as a carbon source or glucose, serving as a plating
control. After six days of growth, colonies were scanned, and the
total area of the colonies from each sample was measured using
the Image Pro Plus 5 software. To compare between the size of
colonies containing an empty vector and the size of colonies
expressing E4orf4 for each Ynd1 mutant, the ratio between total
colony area in the absence and presence of E4orf4 was calculated.
This ratio was normalized to the parallel ratio of colony areas on
glucose plates. This normalization abolished differences created by
fluctuations in yeast concentrations in the various samples. The
ratio obtained was further normalized to the ratio calculated for
the WT Ynd1 protein, and the final values provide a relative
quantitative measure of the toxic effect of E4orf4 on yeast growth
in the presence of WT or mutant Ynd1 constructs. Since colonies
containing an empty vector are larger than colonies expressing
E4orf4, a higher colony size ratio represents a higher ability of the
Ynd1 construct to mediate E4orf4 toxicity.
Immunoblot analysis and coimmunoprecipitation of
yeast proteins
For immunoblots and coimmunoprecipitation experiments,
yeast extracts were prepared by bead-beating cells for 4 min at
4uC in lysis buffer (250 mM NaCl, 50 mM Tris-HCl, pH 7.4,
5 mM EDTA, 0.5% Nonidet P-40, 0.1% Triton X-100, 50 mM
NaF, 100 mM sodium vanadate, 100 nM okadaic acid (Calbio-
chem), 16 complete protease inhibitor mixture (Roche Applied
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extracts, and 2 mg/ml aprotinin (Sigma)). The lysates were spun to
separate beads and debris from the clear lysate. The beads were
washed twice more in the lysis buffer, and immunoprecipitations
were carried out in the same lysis buffer. Antibodies used in this
work included: anti-Myc (9E10) and anti-HA (Covance, Berkeley,
CA), anti-E4orf4 [7], anti-Tpd3p (from J. R. Broach), and anti-
Rbp4 (Neoclone, Madison, WI).
Subcellular Fractionation of Yeast
Yeast cells were lysed by bead beating for 4 minutes at 4uCi n
homogenization buffer (50 mM Tris-HCl pH 7.5, 0.3 M sucrose,
5 mM EDTA, 1 mM EGTA, 5 mg/ml BSA, 2 mM DTT,
protease inhibitors as above). Lysates were centrifuged at
1,000 g for 5 minutes to remove nuclei and partially lysed cells.
The supernatants were centrifuged at 10,000 g for 10 minutes to
pellet the heavy membrane fraction. The resulting supernatants
were centrifuged at 120,000 g for 1 hour. The pellets of this
centrifugation step contained the light membrane fraction, and the
supernatants represented the cytosolic fraction. All centrifugation
steps were done at 4uC. Most of the ER, vacuolar membranes and
plasma membrane are found in the heavy membrane fraction,
whereas the light membrane fraction is enriched in Golgi
membranes [24].
Proteinase K protection assay
Crude membrane extracts were prepared as above, except for
omitting the centrifugation step at 10,000 g. The pellet containing
total cellular membranes was suspended in Proteinase K buffer
(10 mM Triethanolamine pH 7.2, 0.8 M Sorbitol, 1 mM EDTA)
and subsequently treated with one of the following: A) Proteinase
K buffer; B) Proteinase K buffer +1% Triton X-100; C) Proteinase
K buffer +200 mg/ml Proteinase K (New England BioLabs,
Ipswitch, MA); D) Proteinase K buffer +1% Triton X-
100+200 mg/ml Proteinase K. All reactions were incubated at
37uC for 45 minutes, and were stopped by addition of 100% TCA
to the sample. The samples were centrifuged at 18,000 g for 10
minutes at 4uC. The supernatants were discarded, and the pellets
were washed with cold acetone. Dried pellets were suspended in
protein sample buffer and separated by SDS-PAGE.
Image Acquisition and Processing
Yeast colonies were photographed with the Bio-Rad Chemi-
Doc
TM documentation apparatus or scanned using an Epson
Perfection4990scanner.Blotswerescannedusingthesamescanner.
Images were processed using Adobe PhotoShop 5.0 or 7.0 and
colony areas were quantified using the Image Pro Plus 5 software.
Results
Random mutagenesis of Ynd1
To characterize the role of Ynd1 in the signal transduction
pathway induced by E4orf4 and to map Ynd1 protein domains
that are essential for mediation of E4orf4-induced toxicity, a
random mutagenesis approach was initially taken. Plasmids
containing randomly mutagenized Ynd1 DNA were transformed
into ynd1D yeast cells expressing E4orf4 and viable colonies were
selected on galactose plates (both Ynd1 and E4orf4 were expressed
from a galactose-inducible promoter). In parallel, control yeast
samples were transformed with empty vector and E4orf4, or with
WT Ynd1 and E4orf4. The sizes of colonies obtained in the screen
were compared to sizes of control colonies. Colonies which grew
similarly to those obtained by transformation with E4orf4 in the
absence of Ynd1 were expected to express Ynd1 mutants which
were unable to mediate the E4orf4 signal, and may thus contain
biologically-significant mutations. Out of approximately 5,000
transformants growing on glucose plates, 200 normal-sized
colonies grew on galactose plates. Ynd1 expression in these
colonies was assessed using Western Blot analysis. Six of the
colonies expressed wild-type levels of truncated forms of Ynd1.
The other colonies expressed either very low levels of Ynd1 or no
Ynd1 at all (results not shown). Plasmid DNAs extracted from the
yeast colonies expressing WT levels of Ynd1 variants were
sequenced. Sequences of all 6 mutants which were expressed at
wild-type levels revealed a nonsense mutation creating a
premature stop codon. The stop codons replaced codons for
amino acids at positions 136, 243, 318, 356, 360 and 419. Thus,
this approach yielded only mutants expressing truncated Ynd1
proteins containing the N-terminal part of the protein, which is
normally localized to the Golgi lumen [24]. All truncated proteins
lacked the transmembrane domain of Ynd1. These findings
suggested either that the N-terminal part of the protein must be
inserted in the Golgi lumen and therefore the transmembrane
domain should be retained to facilitate signal transduction, or that
the C-terminal cytosolic domain of the protein was required for
mediation of the E4orf4 toxic signal.
Mediation of E4orf4-induced toxicity by Ynd1 truncation
mutants
To further investigate which domain of Ynd1 was required for
the mediation of E4orf4-induced toxicity, three Ynd1 mutants
containing N-terminal deletions were generated. Mutant 371-
Ynd1 encodes Ynd1 with an N-terminal deletion of amino acids
1–370 of the WT protein, 468-Ynd1 encodes Ynd1 with an N-
terminal deletion of amino acids 1–467 of the WT protein, and
mutant 518-Ynd1 contains only the cytosolic tail of Ynd1 (amino
acids 518–630), lacking the transmembrane domain. In addition,
mutants lacking both N-terminal 370 or 467 residues and the C-
terminal 99 amino acids were generated (371-Ynd1-531 and 468-
Ynd1-531 respectively). The WT protein as well as all mutants
contained an N-terminal Myc-tag and a C-terminal HA-tag and
were expressed from a galactose-inducible promoter. The
schematic structure of the mutants and the wild-type protein can
be seen in Fig. 1.
Figure 1. Ynd1 constructs. A schematic representation of WT and
mutant Ynd1 proteins is shown. The dark grey lines in the WT protein
represent apyrase-conserved-domains found in the N-terminal, luminal
part of the protein, and the light grey lines represent hydrophobic
domains. The rightmost hydrophobic domain was determined to be the
transmembrane domain [26]. All Ynd1 constructs carry a Myc tag at
their amino terminus (N) and a HA tag at the carboxyl terminus (C).
doi:10.1371/journal.pone.0015539.g001
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the mutant constructs were introduced into ynd1D yeast cells
expressing E4orf4 from a galactose-inducible promoter or into
control ynd1D cells containing an empty vector and a serial dilution
assay was performed (Fig. 2A). ynd1D cells expressing WT Ynd1 or
an empty vector served as controls. It should be noted that lack of
YND1 conferred only partial resistance to E4orf4 toxicity,
indicated by the smaller colony sizes in ynd1D cells expressing
E4orf4 in comparison to ynd1D cells containing vector alone
(Fig. 2A, vector). However, colony sizes were further reduced
when WT Ynd1 was added to the cells ([27] and Fig. 2). When
comparing sizes of colonies obtained by transformation of ynd1D
cells with E4orf4 and the various Ynd1 deletion mutants, it
appeared that the three N-terminal deletion mutants could
transduce the E4orf4 signal at least partially, whereas the short
371-Ynd1-531 and 468-Ynd1-531 mutants did not efficiently
transduce the signal (compare the sizes of individual colonies).
However, using this assay it was impossible to quantify the relative
performance of the mutants, since they also had varying effects on
yeast growth in the absence of E4orf4. For this reason, a
quantitative colony size comparison assay was designed, which
took into account the differential effects of the various Ynd1
mutants on yeast growth in the absence and presence of E4orf4
(described in detail in the materials and methods section). ynd1D
cells were transformed with a plasmid expressing WT Ynd1, an
empty vector, or one of the mutants, together with an E4orf4-
expressing plasmid or its corresponding empty vector. The
transformants were grown overnight at 30uC in liquid medium
containing glucose as a carbon source, in which neither E4orf4 nor
the Ynd1 constructs were expressed, and were then diluted and
plated for the quantitative assay. Colony size ratios calculated for
each of the mutants, as well as the ratios for WT Ynd1 and the
empty vector control can be seen in Fig. 2B. The results
demonstrate that mutant 371-Ynd1 mediated E4orf4-induced
growth arrest less well than wild-type Ynd1 (66% of WT) but
E4orf4-induced toxicity was higher in its presence than it was
when Ynd1 was absent (vector, 28% of WT). Mutant 468-Ynd1
mediated the E4orf4 toxic signal 1.5-fold better than the WT
protein. Compared with the 371-Ynd1 mutant, 468-Ynd1 lacks a
hydrophobic domain adjacent to the transmembrane domain,
which may affect the topology and activity of Ynd1 protein
domains both inside and outside the Golgi. Surprisingly, mutant
518-Ynd1, containing only the cytosolic tail of Ynd1, was 1.4-fold
more efficient than the WT protein in mediating the E4orf4 signal.
In contrast, the short Ynd1 mutants (371-Ynd1-531 and 468-
Ynd1-531), lacking most of the cytosolic tail in addition to their N-
terminal deletions, did not transduce the E4orf4 signal significantly
better than the empty vector. These results suggest that the
cytosolic tail of Ynd1 mediates E4orf4 toxicity even in the absence
of the luminal and transmembrane domains of the protein. It
should be noted that a similar effect of the 518-Ynd1 mutant was
observed using non-tagged 518-Ynd1 and WT proteins (not
shown), indicating that the tags did not have an independent effect
in this system.
Membrane localization of Ynd1 proteins and E4orf4
The differences in the ability of Ynd1 mutants to mediate
E4orf4-induced toxicity could possibly reflect altered subcellular
localizations. To examine whether Ynd1 mutants remained
membrane-associated, light and heavy membranes were separated
from cytosol and nuclei by differential centrifugation, and the
presence of WT and mutant Ynd1 proteins in the various fractions
was compared by a Western blot. It has been previously reported
that most of the ER, vacuolar membranes and plasma membrane
are found in the heavy membrane fraction, whereas the light
membrane fraction is enriched in Golgi membranes [24]. As seen
in Fig. 3A, WT Ynd1 could only be detected in the membrane
fractions (both heavy and light), whereas a small percentage of
mutant proteins 468-Ynd1 and 468-Ynd1-531 could be found in
the cytosol. However, since this minor cytosolic presence of the
mutants did not correlate with their efficiency in mediating the
E4orf4 signal (Fig. 2), it may not be significant. The finding that
mutant 468-Ynd1 appears as two bands, whereas the other
mutants and the WT Ynd1 proteins appear as a single protein
Figure 2. Transduction of E4orf4 toxicity by WT and mutant
Ynd1 constructs. A. ynd1D cells transformed with WT Ynd1 or mutant
Ynd1 constructs in the presence or absence of E4orf4 were serially
diluted (1:5) and grown on glucose and galactose plates. B. ynd1D cells
were transformed with WT Ynd1 or mutant constructs in the presence
or absence of E4orf4. Yeast cell concentrations were equalized
according to OD measurements, and equal amounts of yeast were
grown on glucose and galactose plates. A quantitative comparison of
the ability of WT and mutant Ynd1 constructs to mediate the E4orf4
toxic signal was performed as described in the Materials and Methods
section, and reflects relative colony sizes in the presence and absence of
E4orf4. The activity of WT Ynd1 was defined as 1. Three experiments
were carried out containing 2 duplicates each. Error bars represent the
standard error.
doi:10.1371/journal.pone.0015539.g002
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glycosylation of this specific mutant. Mutant 518-Ynd1 was
observed to be partially cytosolic, but densitometric analysis of
the blot revealed that 50% of this protein remained membrane-
associated. In contrast, 90% of the RNA polymerase II Rpb4
subunit, which was reported to localize both to nuclei and
cytoplasm, but not to membranes [30], was found in the cytosol.
These results indicate that the subcellular fractionation was
efficient and that indeed mutant 518-Ynd1 was partially
membrane-associated despite lacking the transmembrane domain.
Since the cytosolic tail of Ynd1 was partially membrane-
associated and appeared to mediate the E4orf4 signal, we
examined whether E4orf4 was also associated with the cytosolic
face of membranes. First we used differential centrifugation to
determine whether E4orf4 was membrane-associated. Fig. 3B
demonstrates that E4orf4 co-purified with both light and heavy
membrane fractions, but was not found freely in the cytoplasm,
whereas the PP2A-A/Tpd3 subunit was found both in membranes
and in the cytoplasm. Interestingly, membrane localization of
E4orf4 was not dependent on the presence of Ynd1, since the
association of the viral protein with membranes was similar in the
presence or absence of Ynd1. To confirm that E4orf4 localized to
the cytoplasmic face of membranes, a protease digestion
protection assay was used. This assay is based on the fact that
cytoplasmic-facing domains of organelle membrane proteins can
be digested by proteases in intact membranes in the absence of
membrane solubilizing agents such as Triton X-100, whereas
protein domains that are not accessible to the proteases can only
be digested after membrane solubilization. Crude membrane
fractions were isolated and subjected to Proteinase K digestion in
the absence or presence of Triton X-100, as previously described
[24]. Fig. 3C demonstrates that Proteinase K digestion of intact
membranes (in the absence of Triton X-100) caused an almost
complete disappearance of E4orf4, indicating that the majority of
this protein was found at the cytosolic face of the membrane,
accessible to protease digestion. At the same time, only the
cytosolic tail of Ynd1 was degraded by Proteinase K in the absence
of Triton X-100, as determined by detection of the amino terminal
Myc tag fused to Ynd1, and as was previously reported by Zhong
and Guidotti [24]. The 518-Ynd1 cytosolic mutant was completely
digested by the protease in the absence of Triton X-100,
confirming the conclusion that it associated with the Golgi
apparatus at its cytosolic face.
Coimmunoprecipitation of Ynd1 mutants with E4orf4
We have previously shown that Ynd1 associates with E4orf4
[27]. To investigate whether Ynd1 mutants mediating the E4orf4
toxic signal, and specifically the cytosolic mutant, have retained
the ability to interact with E4orf4, coimmunoprecipitation
experiments were carried out. Fig. 4 demonstrates that WT and
several mutant Ynd1 proteins were coimmunoprecipitated with
E4orf4. However, only low levels of the short non-functional Ynd1
mutants were found in E4orf4 immune complexes, compared with
the functional Ynd1 proteins (compare for example 371-Ynd1 and
371-Ynd1-531). The cytosolic 518-Ynd1 mutant was expressed at
Figure 3. Subcellular localization of Ynd1 proteins and E4orf4.
A. ynd1D yeast cells expressing the indicated Ynd1 constructs were
subjected to subcellular fractionation by differential centrifugation, and
the presence of Ynd1 proteins in the various fractions was determined
by a Western blot analysis. Rpb4 is a RNA polymerase II subunit which
shuttles between the nucleus and the cytosol, and served here as a
cytosolic fractionation marker. H: heavy membranes. L: light mem-
branes. C: cytosol. B. ynd1D yeast cell extracts expressing vector control
or WT Ynd1 together with E4orf4 were subjected to subcellular
fractionation by differential centrifugation. Western blots were stained
sequentially with antibodies recognizing tagged Ynd1, E4orf4, and the
Tpd3 subunit of PP2A. C. Crude membranes were prepared from yeast
cells expressing the indicated Ynd1 constructs or E4orf4, and were
subjected to a Proteinase K protection assay in the presence or absence
of Triton X-100. Proteins were analyzed by Western blots stained with
the indicated antibodies. The Myc tag is fused to the amino terminus of
Ynd1 constructs and the HA tag is fused to the cytosolic carboxyl tail. In
this experiment, a longer exposure of the 518-Ynd1-containing blot
allowed the presentation of a stronger signal in the blot to confirm that
most of the protein was degraded by Proteinase K.
doi:10.1371/journal.pone.0015539.g003
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pitated with E4orf4. Only very low non-specific binding of Ynd1
to the E4orf4-specific antibodies was observed in the absence of
E4orf4. Thus, the Ynd1 cytosolic tail can associate specifically with
E4orf4.
Discussion
E4orf4-induced toxicity in yeast has been previously shown to
require the Cdc55 subunit of PP2A and the Golgi apyrase Ynd1.
Both proteins contribute additively to E4orf4 toxicity, and interact
physically and functionally [27]. Ynd1 contains an active
nucleoside hydrolysis site located in the Golgi lumen, a
transmembrane domain, and a cytosolic tail [24,26]. In this work
we identified the Ynd1 cytosolic tail as a Ynd1 domain required
for transduction of the E4orf4 signal. We have shown that this
domain, when detached from the rest of the protein, acts as a
membrane-associated protein (Fig. 3), can mediate the E4orf4
signal (Fig. 2), and associates with the E4orf4 protein (Fig. 4).
These findings are consistent with previous results showing that
the luminal apyrase activity is not required for mediation of the
E4orf4 signal [27]. Although E4orf4 is found at the cytosolic face
of yeast membranes, as judged by cell fractionation and Proteinase
K protection assays (Fig. 3), membrane localization of the viral
protein is not dependent exclusively on the presence of Ynd1, since
it was found to be membrane-associated in ynd1D cells (Fig. 3B).
Based on proteomic prediction tools (Sosui, DAS, TMPRED,
TOPPRED), E4orf4 may contain a hydrophobic patch that
creates an amphipathic helix. Thus it may be recruited to cell
membranes either through its hydrophobic region or by
interacting with other membrane-associated proteins. E4orf4 and
Ynd1 were found both in light and heavy membrane fractions,
suggesting that they associate with both the Golgi apparatus and
additional cell membrane compartments. Indeed, mammalian
Ynd1 was previously found in lysosomal/autophagic vacuole
membranes [31], as well as in the Golgi (our unpublished results).
The cytosolic 518-Ynd1 mutant was usually expressed at lower
levels than the other mutants (Fig. 4), but transduced the E4orf4
toxic signal at least as well as these mutants, if not better (Fig. 2). It
is possible that the flexibility of the cytoplasmic tail is dictated, at
least in part, by the mechanism by which this domain is anchored
to the membrane. It has been previously suggested that most of the
COOH-terminal cytosolic tail of Ynd1 may bind to the
cytoplasmic face of Golgi membranes because of its highly positive
charge [24]. The absence of additional membrane anchoring
through the transmembrane domain may increase the flexibility of
the peripherally-anchored tail and enhance its accessibility to
interacting proteins.
Our results and previous reports on Ynd1-associating proteins
suggest the possibility that the Ynd1 cytosolic tail mediates E4orf4
toxicity by acting as a scaffold for a multi-protein complex which is
targeted by E4orf4. We have previously shown that E4orf4
dissociates Cdc55 from Ynd1 [27], however this finding could
represent the disruption of a multi-protein complex which includes
Cdc55 and other proteins as well. The Saccharomyces Genome
Database cites at least 10 membrane proteins which physically
associate with Ynd1, as determined by a two-hybrid screen and by
affinity capture experiments [32,33]. Six of these proteins, Erd1,
Erv29, Pmp2, Sys1, Yip3 and a putative YPL264C protein, were
found in the BioGRID database to interact with each other, and
they could thus be part of a large protein complex, which includes
Ynd1. Interestingly, the yeast interaction screen used to identify
these proteins, the ‘‘split-ubiquitin membrane yeast two-hybrid
system’’, was designed in such a way that it favored the
identification of interactions between carboxyl termini of integral
membrane proteins which are localized at the cytoplasmic faces of
cellular membranes [32]. As a result, it is likely that Ynd1-
associating proteins identified by this method interact with the
Ynd1 cytosolic tail, and are thus also accessible for interaction with
E4orf4. Moreover, since this interaction screen was designed to
reveal interactions between integral membrane proteins, it could
not reveal cytosolic proteins that may be recruited to membranes,
such as Cdc55. Thus it is possible that the Ynd1 cytosolic tail
recruits additional peripheral membrane or cytosolic proteins.
Since E4orf4 can associate with membranes in the absence of
Ynd1 (Fig. 3B), it may interact with other members of a Ynd1
multi-protein complex. This interaction could possibly lead to
dissociation of the complex and to further transduction of the
E4orf4 toxic signal. Alternatively, E4orf4 could bind both the
Ynd1 cytosolic tail and additional membrane proteins and bring
them together.
Four of the six Ynd1-associating proteins which are potential
members of a multi-protein complex are involved in ER to Golgi
vesicle-mediated transport (Erv29 and Yip3) and vesicle organi-
zation (Sys1) or ER retention of cargo proteins (Erd1). Two of
these proteins, Yip3 and Sys1, have also been implicated in
endosomal trafficking. Three other Ynd1-interacting proteins,
which were not found to interact with other Ynd1-binding
proteins, were classified as vacuole-associated proteins. Thus it
appears that Ynd1 associates with several components of both
early and late secretory pathways in yeast, and it is possible that
E4orf4 interacts with a secretory protein complex anchored to the
Ynd1 cytosolic tail.
Figure 4. Coimmunoprecipitation of E4orf4 with WT and mutant Ynd1 proteins. E4orf4 was immunoprecipitated from ynd1D yeast cells
expressing the indicated Ynd1 proteins. Western blots of the immune complexes (IP) and input lysates (10% of IP) were stained with the indicated
antibodies.
doi:10.1371/journal.pone.0015539.g004
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promotes transport of recycling endosomes to the Golgi apparatus
and inhibits recycling of protein cargos to the plasma membrane
through its regulation of Src family kinases, Cdc42, actin
dynamics, and Rab11a [34]. These events lead to Golgi
membrane scattering and contribute to cell death. Although yeast
cells lack Src family members, it is possible that E4orf4 may also
utilize a backup mechanism which allows it to interact directly
with components of the secretory pathway to affect protein
trafficking, thus further transducing its toxic signal. It is not
currently known whether early or late steps in protein sorting may
be affected by direct interaction with E4orf4.
It has been previously reported that the E4orf4-PP2A complex
interacts with the anaphase-promoting complex/cyclosome (APC/
C) and modulates its activity at both G2/M and S phases of the
cell cycle, thus contributing to E4orf4-induced toxicity [21,35].
Furthermore, we have shown that Ynd1 interacts genetically with
both the Cdc20 and Cdh1/Hct1 activating subunits of the APC/C
[27]. These results indicate that PP2A, Ynd1 and the APC/C are
all part of the E4orf4 network inducing toxicity. These three
effectors could interact either at the cytoplasmic face of the Golgi,
or at other locations, such as spindle poles which were reported to
co-localize not only with the APC/C [36], but also with regulators
of endocytic traffic, such as clathrin and rab11 [37,38]. Future
identification of Ynd1-containing complexes in the presence and
absence of E4orf4 will provide more information on their
contribution to E4orf4-induced toxicity.
In summary, we propose that the Ynd1 cytosolic tail may act as
a scaffolding domain allowing the association of E4orf4 with Ynd1
and additional Ynd1 partners, and this interaction contributes to
transduction of the E4orf4 toxic signal.
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